U87MG and LN229 cells contain distinct gene mutations [44] and express different biomarkers, including the latent-TGFβ activating integrin αvβ8, which is robustly expressed in LN229 GBM cells but expressed at much lower levels in U87MG cells [45, 46]. This evidence concerns the gene TGFB1 and glioblastoma.